Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,694 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Glomerular cell apoptosis in human lupus nephritis.
Makino H, Sugiyama H, Yamasaki Y, Maeshima Y, Wada J, Kashihara N. Makino H, et al. Among authors: sugiyama h. Virchows Arch. 2003 Jul;443(1):67-77. doi: 10.1007/s00428-003-0827-x. Epub 2003 May 15. Virchows Arch. 2003. PMID: 12750884
Pathogenesis of IgA nephropathy.
Wada J, Sugiyama H, Makino H. Wada J, et al. Among authors: sugiyama h. Semin Nephrol. 2003 Nov;23(6):556-63. doi: 10.1053/s0270-9295(03)00134-7. Semin Nephrol. 2003. PMID: 14631563 Review.
Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis.
Saito D, Maeshima Y, Nasu T, Yamasaki H, Tanabe K, Sugiyama H, Sonoda H, Sato Y, Makino H. Saito D, et al. Among authors: sugiyama h. Am J Physiol Renal Physiol. 2011 Apr;300(4):F873-86. doi: 10.1152/ajprenal.00503.2010. Epub 2011 Jan 12. Am J Physiol Renal Physiol. 2011. PMID: 21228103 Free article.
We recently reported the therapeutic effects of vasohibin-1 (VASH-1), an endogenous angiogenesis inhibitor, in a type 1 diabetic nephropathy model (Nasu T, Maeshima Y, Kinomura M, Hirokoshi-Kawahara K, Tanabe K, Sugiyama H, Sonoda H, Sato Y, Makino H. …
We recently reported the therapeutic effects of vasohibin-1 (VASH-1), an endogenous angiogenesis inhibitor, in a type 1 diabetic nephropathy …
Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.
Takatori Y, Akagi S, Sugiyama H, Inoue J, Kojo S, Morinaga H, Nakao K, Wada J, Makino H. Takatori Y, et al. Among authors: sugiyama h. Clin J Am Soc Nephrol. 2011 Jun;6(6):1337-44. doi: 10.2215/CJN.10041110. Epub 2011 Apr 14. Clin J Am Soc Nephrol. 2011. PMID: 21493740 Free PMC article. Clinical Trial.
2,694 results